The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Fri., Feb. 22, 3:52 AM

Slide #2. Celldex Therapeutics, Inc. (NASDAQ:CLDX) 1 for 15 Reverse Split

Announced: 2/8/2019
Stock Split: 1 for 15
Record Date: 2/8/2019
Pay Date: 2/11/2019
CLDX Optionable?: Yes

Celldex Therapeutics is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. Co.'s drug candidates, including antibodies, antibody-drug conjugates and other protein-based therapeutics are derived from a set of technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. As of Dec 31 2017, Co. had seven drug candidates in clinical development including glembatumumab vedotin (also referred to as CDX-011), varlilumab (also referred to as CDX-1127), CDX-3379, CDX-014, CDX-1140, CDX-301 and CDX-1401.
CLDX Detailed Information Page & Split History »

Company Name: 
Celldex Therapeutics, Inc.
Website: 
www.celldex.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding CLDX: 
4
Total Market Value Held by ETFs: 
$31983
Total Market Capitalization: 
$67.00M
% of Market Cap. Held by ETFs: 
0.05%

Open the CLDX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
96th percentile
(ranked higher than approx. 96% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.